Published in J Biol Chem on February 06, 1998
Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes (2009) 8.70
Gluttony, sloth and the metabolic syndrome: a roadmap to lipotoxicity. Trends Endocrinol Metab (2010) 2.58
Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities. Antioxid Redox Signal (2010) 2.11
Lipotoxicity of the pancreatic beta-cell is associated with glucose-dependent esterification of fatty acids into neutral lipids. Diabetes (2001) 1.70
Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis. Mol Cell Biol (2003) 1.60
Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci U S A (1999) 1.58
Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc Natl Acad Sci U S A (1998) 1.53
Cholesterol in islet dysfunction and type 2 diabetes. J Clin Invest (2008) 1.32
Obesity and fat quantification in lean tissues using three-point Dixon MR imaging. Pediatr Radiol (2005) 1.31
Pancreatic islet beta-cell and oxidative stress: the importance of glutathione peroxidase. FEBS Lett (2007) 1.16
Beta-cell deterioration during diabetes: what's in the gun? Trends Endocrinol Metab (2009) 1.11
Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals. Endocr Rev (2013) 1.10
Research resource: nuclear hormone receptor expression in the endocrine pancreas. Mol Endocrinol (2008) 1.08
Noninsulin glucose-lowering agents for the treatment of patients on dialysis. Nat Rev Nephrol (2013) 0.99
PPAR-γ activation increases insulin secretion through the up-regulation of the free fatty acid receptor GPR40 in pancreatic β-cells. PLoS One (2013) 0.98
The dual PPARalpha/gamma agonist, ragaglitazar, improves insulin sensitivity and metabolic profile equally with pioglitazone in diabetic and dietary obese ZDF rats. Br J Pharmacol (2005) 0.95
PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction. J Lipid Res (2009) 0.95
Pioglitazone acutely reduces insulin secretion and causes metabolic deceleration of the pancreatic beta-cell at submaximal glucose concentrations. Endocrinology (2009) 0.94
Expression of apolipoprotein B in the kidney attenuates renal lipid accumulation. J Biol Chem (2010) 0.92
Caveolins sequester FA on the cytoplasmic leaflet of the plasma membrane, augment triglyceride formation, and protect cells from lipotoxicity. J Lipid Res (2010) 0.88
Expression and functional activity of PPARgamma in pancreatic beta cells. Br J Pharmacol (2004) 0.87
Adenylosuccinate Is an Insulin Secretagogue Derived from Glucose-Induced Purine Metabolism. Cell Rep (2015) 0.86
Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells. Proc Natl Acad Sci U S A (2014) 0.86
Nutrigenomics, beta-cell function and type 2 diabetes. Curr Genomics (2007) 0.84
Palmitate-induced beta-cell dysfunction is associated with excessive NO production and is reversed by thiazolidinedione-mediated inhibition of GPR40 transduction mechanisms. PLoS One (2008) 0.82
Identification of differential responses to an oral glucose tolerance test in healthy adults. PLoS One (2013) 0.81
Lipotoxicity and decreased islet graft survival. Diabetes Care (2009) 0.81
Small-molecule inhibition of inflammatory β-cell death. Diabetes Obes Metab (2013) 0.80
Apoptosis rate and transcriptional response of pancreatic islets exposed to the PPAR gamma agonist Pioglitazone. Diabetol Metab Syndr (2013) 0.78
Chronic treatment with the thiazolidinedione, MCC-555, is associated with reductions in nitric oxide synthase activity and beta-cell apoptosis in the pancreas of the Zucker Diabetic Fatty rat. Int J Exp Pathol (2003) 0.78
Short insulin tolerance test can determine the effects of thiazolidinediones treatment in type 2 diabetes. Yonsei Med J (2008) 0.75
Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature (2002) 28.79
Analysis of oncogenic signaling networks in glioblastoma identifies ASPM as a molecular target. Proc Natl Acad Sci U S A (2006) 6.33
Lipotoxic heart disease in obese rats: implications for human obesity. Proc Natl Acad Sci U S A (2000) 5.65
RESOURCERER: a database for annotating and linking microarray resources within and across species. Genome Biol (2001) 4.79
Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest (1970) 4.74
Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A (1998) 4.72
Human myocyte-specific enhancer factor 2 comprises a group of tissue-restricted MADS box transcription factors. Genes Dev (1992) 4.10
Beta-cell lipotoxicity in the pathogenesis of non-insulin-dependent diabetes mellitus of obese rats: impairment in adipocyte-beta-cell relationships. Proc Natl Acad Sci U S A (1994) 4.01
Pancreatic glucagon secretion in normal and diabetic subjects. Am J Med Sci (1969) 3.42
Enrichment of gene-coding sequences in maize by genome filtration. Science (2003) 3.41
Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med (1970) 3.27
Direct antidiabetic effect of leptin through triglyceride depletion of tissues. Proc Natl Acad Sci U S A (1997) 3.07
Purification and characterization of the nuclear RNase P holoenzyme complex reveals extensive subunit overlap with RNase MRP. Genes Dev (1998) 2.97
Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. Eur J Immunol (1996) 2.90
Functional subdivision of islets of Langerhans and possible role of D cells. Lancet (1975) 2.83
Biomedical applications of collagen. Int J Pharm (2001) 2.76
Subunit interaction maps for the regulatory particle of the 26S proteasome and the COP9 signalosome. EMBO J (2001) 2.66
Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest (1968) 2.60
Lipoapoptosis in beta-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem (1998) 2.59
Glucagon levels and metabolic effects in fasting man. J Clin Invest (1970) 2.58
The essential role of glucagon in the pathogenesis of diabetes mellitus. Lancet (1975) 2.54
The effects of secretin, pancreozymin, and gastrin on insulin and glucagon secretion in anesthetized dogs. J Clin Invest (1967) 2.53
Insulin within islets is a physiologic glucagon release inhibitor. J Clin Invest (1984) 2.52
Hyperglycaemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia (1985) 2.48
Characterization of the responses of circulating glucagon-like immunoreactivity to intraduodenal and intravenous administration of glucose. J Clin Invest (1968) 2.46
Role of nitric oxide in obesity-induced beta cell disease. J Clin Invest (1997) 2.45
Pancreatic beta-cells in obesity. Evidence for induction of functional, morphologic, and metabolic abnormalities by increased long chain fatty acids. J Biol Chem (1995) 2.43
Bevacizumab and chemotherapy for recurrent glioblastoma: a single-institution experience. Neurology (2009) 2.41
Regulation of fatty acid homeostasis in cells: novel role of leptin. Proc Natl Acad Sci U S A (1999) 2.33
Oligogalacturonic acid and chitosan reduce stomatal aperture by inducing the evolution of reactive oxygen species from guard cells of tomato and Commelina communis. Plant Physiol (1999) 2.32
Human and rat TR4 orphan receptors specify a subclass of the steroid receptor superfamily. Proc Natl Acad Sci U S A (1994) 2.16
The effect of experimental insulin deficiency on glucagon secretion. J Clin Invest (1971) 2.15
Disappearance of body fat in normal rats induced by adenovirus-mediated leptin gene therapy. Proc Natl Acad Sci U S A (1996) 2.15
Leptin, troglitazone, and the expression of sterol regulatory element binding proteins in liver and pancreatic islets. Proc Natl Acad Sci U S A (2000) 2.11
Inhibition of glucose transport into rat islet cells by immunoglobulins from patients with new-onset insulin-dependent diabetes mellitus. N Engl J Med (1990) 2.01
Quantitation of endocrine cell content in the pancreas of nondiabetic and diabetic humans. Diabetes (1982) 1.94
Reversing adipocyte differentiation: implications for treatment of obesity. Proc Natl Acad Sci U S A (1999) 1.92
Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation (2000) 1.91
Somatostatinoma syndrome. Biochemical, morphologic and clinical features. N Engl J Med (1979) 1.88
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem (2001) 1.87
Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol (2001) 1.87
Effects of starvation on plasma pancreatic glucagon in normal man. Diabetes (1969) 1.86
Glucagon and the insulin: glucagon ratio in diabetes and other catabolic illnesses. Diabetes (1971) 1.85
Underexpression of beta cell high Km glucose transporters in noninsulin-dependent diabetes. Science (1990) 1.85
Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes (2001) 1.84
Anti-emetic effect of ondansetron and palonosetron in thyroidectomy: a prospective, randomized, double-blind study. Br J Anaesth (2012) 1.80
Physiology and pathophysiology of glucagon. Physiol Rev (1976) 1.79
A glucagon-secreting alpha-cell carcinoma of the pancreas. N Engl J Med (1966) 1.79
A prediction model for type 2 diabetes risk among Chinese people. Diabetologia (2008) 1.78
Entero-insular axis. Arch Intern Med (1969) 1.74
The use of the GlideScope for tracheal intubation in patients with ankylosing spondylitis. Br J Anaesth (2006) 1.74
Comparison of propofol deep sedation versus moderate sedation during endosonography. Dig Dis Sci (2010) 1.72
The role of aminogenic glucagon secretion in blood glucose homeostasis. J Clin Invest (1969) 1.71
Characterization of response of circulating glucagon to intraduodenal and intravenous administration of amino acids. J Clin Invest (1968) 1.71
Large glucagon immunoreactivity in extracts of pancreas. J Biol Chem (1970) 1.70
Control of pancreatic glucagon secretion by glucose. Diabetes (1969) 1.69
Glucagon physiology and pathophysiology in the light of new advances. Diabetologia (1985) 1.69
Evidence for subdivision within the M molecular form of Anopheles gambiae. Mol Ecol (2007) 1.67
Novel form of lipolysis induced by leptin. J Biol Chem (1999) 1.67
Human amniotic fluid-derived stem cells have characteristics of multipotent stem cells. Cell Prolif (2007) 1.67
Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM. Diabetes (1997) 1.66
Hyperglucagonemia in diabetic ketoacidosis. Its prevalence and significance. Am J Med (1973) 1.66
Glucagon and the A cell: physiology and pathophysiology (first two parts). N Engl J Med (1981) 1.66
Liporegulation in diet-induced obesity. The antisteatotic role of hyperleptinemia. J Biol Chem (2000) 1.65
Protection against lipoapoptosis of beta cells through leptin-dependent maintenance of Bcl-2 expression. Proc Natl Acad Sci U S A (1998) 1.64
Abnormal pancreatic alpha-cell function in bacterial infections. N Engl J Med (1973) 1.62
Induction by leptin of uncoupling protein-2 and enzymes of fatty acid oxidation. Proc Natl Acad Sci U S A (1997) 1.59
Hypertrophy and hyperplasia of somatostatin-containing D-cells in diabetes. Proc Natl Acad Sci U S A (1976) 1.59
Troglitazone prevents mitochondrial alterations, beta cell destruction, and diabetes in obese prediabetic rats. Proc Natl Acad Sci U S A (1999) 1.58
Hyperglucagonaemia after burns. Lancet (1974) 1.56
Recurrent cases of corticosteroid-induced mood disorder: clinical characteristics and treatment. J Clin Psychiatry (2000) 1.55
A new video intubating device: trachway intubating stylet. Anaesthesia (2009) 1.55
Role of peroxisome proliferator-activated receptor alpha in disease of pancreatic beta cells. Proc Natl Acad Sci U S A (1998) 1.53
IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ (2009) 1.53
Defective fatty acid-mediated beta-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes. J Biol Chem (1996) 1.53
Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence. Diabetologia (1995) 1.52
The Banting Memorial Lecture 1975. Diabetes and the alpha cell. Diabetes (1976) 1.51
Evidence that down-regulation of beta-cell glucose transporters in non-insulin-dependent diabetes may be the cause of diabetic hyperglycemia. Proc Natl Acad Sci U S A (1990) 1.51
Congestion of right liver graft in living donor liver transplantation. Transplantation (2001) 1.51
Roles of insulin resistance and beta-cell dysfunction in dexamethasone-induced diabetes. J Clin Invest (1992) 1.50
Sequence analysis of a rainbow trout cDNA library and creation of a gene index. Cytogenet Genome Res (2003) 1.46
Amygdala and bed nucleus of the stria terminalis: differential roles in fear and anxiety measured with the acoustic startle reflex. Philos Trans R Soc Lond B Biol Sci (1997) 1.46
Long-term vitamin C supplement use and prevalence of early age-related lens opacities. Am J Clin Nutr (1997) 1.46
More direct evidence for a malonyl-CoA-carnitine palmitoyltransferase I interaction as a key event in pancreatic beta-cell signaling. Diabetes (1994) 1.45
Effects of secretin on insulin and glucagon in portal and peripheral blood in man. Lancet (1966) 1.44